**Background**
Mitochondrial dysfunction and oxidative stress are central drivers in the pathogenesis of various cardiovascular and degenerative neurologic and neuromuscular diseases. The electron transport chain, located within the inner mitochondrial membrane, is critical for the production of adenosine triphosphate (ATP), which serves as the primary energy source for most cellular processes. A deficiency in mitochondrial bioenergetics often leads to cellular damage and organ failure, particularly in high-energy tissues such as the heart and brain. Consequently, targeting mitochondrial function and enhancing antioxidant defenses have become key strategies in therapeutic research. In this context, we will introduce a potent antioxidant and essential cofactor – Coenzyme Q10.
**Definition**
Coenzyme Q10 is a human endogenous metabolite and a member of the benzene quinones structure classification with a molecular weight of 863.34 and the Coenzyme Q10 Formula C59H90O4. It serves as an obligatory member of the respiratory chain and a potent antioxidant agent.
**In Vitro and In Vivo Studies**
The Coenzyme Q10 biological activity is characterized by its ability to facilitate ATP formation and provide antioxidant protection through direct reaction with free radicals or by regenerating tocopherol and ascorbate from their oxidized states. Coenzyme Q10 in vitro studies have demonstrated its impact on cell viability; for instance, in human FRDA primary patient fibroblasts, Coenzyme Q10 exhibited a GI50 value of 220 μM after 48 hours of treatment as measured by a calcein-AM-based cell viability assay.
Regarding Coenzyme Q10 in vivo applications, the compound’s hydrophobicity and large molecular weight typically limit dietary absorption, although solubilized formulations can enhance bioavailability. Pharmacokinetic data indicate a Tmax of approximately 6 hours and an elimination half-life of about 33 hours, with plasma reference intervals in healthy subjects ranging from 0.40 to 1.91 mM. Animal models have shown that high doses of Coenzyme Q10 are taken up by heart and brain mitochondria. Specifically, administration in 12-month-old rats significantly increased mitochondrial concentrations in the cerebral cortex. Furthermore, oral administration markedly attenuated striatal lesions induced by 3-nitropropionic acid and significantly extended the lifespan of transgenic mouse models of familial amyotrophic lateral sclerosis. In conclusion, Coenzyme Q10 is an essential mitochondrial cofactor and antioxidant that holds significant potential for treating bioenergetic and oxidative stress-related disorders.
Keywords
Coenzyme Q10, 303-98-0, CoQ10, Ubiquinone-10, Ubidecarenone, Coenzyme Q 10, Coenzyme Q-10, CoQ 10, CoQ-10, Ubiquinone10, Ubiquinone 10, Endogenous Metabolite, Reactive Oxygen Species (ROS), Ferroptosis
References
[1] Yang YK, et al. Coenzyme Q10 treatment of cardiovascular disorders of ageing including heart failure, hypertension and endothelial dysfunction. Clin Chim Acta. 2015 Oct 23;450:83-9.
[2] Bhagavan HN, et al. Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Radic Res. 2006 May;40(5):445-53.
[3] Matthews RT, et al. Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8892-7.